A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fund Several rapid, point-o
View source →https://www.who.int/news/item/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countriesHash 0xa45c71a3c784157b3eda5a655e3f7466c0ffd7758a99e58a95c7a7dd5a7ff5ba
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.